Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.

Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, Fagrouch Z, Berland JL, Komurian-Pradel F, Duverger B, Himoudi N, Staib C, Meyr M, Whelan M, Whelan JA, Adams VC, Larrea E, Riezu JI, Lasarte JJ, Bartosch B, Cosset FL, Spaan WJ, Diepolder HM, Pape GR, Sutter G, Inchauspe G, Heeney JL.

Hepatology. 2007 Mar;45(3):602-13. Erratum in: Hepatology. 2007 Jun;45(6):1590. Adams, Victoria A [corrected to Adams, Victoria C]; Lasarte, Juan José [corrected to Lasarte, Juan J].

PMID:
17326154
2.

Success and failure of virus-specific T cell responses in hepatitis C virus infection.

Neumann-Haefelin C, Thimme R.

Dig Dis. 2011;29(4):416-22. doi: 10.1159/000329807. Epub 2011 Aug 30. Review.

PMID:
21894013
3.

Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine.

Thimme R, Neumann-Haefelin C, Boettler T, Blum HE.

Biol Chem. 2008 May;389(5):457-67. Review.

PMID:
18953713
4.

Studies of hepatitis C virus in chimpanzees and their importance for vaccine development.

Bukh J, Forns X, Emerson SU, Purcell RH.

Intervirology. 2001;44(2-3):132-42. Review.

PMID:
11509874
5.

Evaluation of hepatitis C virus protein epitopes for vaccine development.

Koshy R, Inchauspé G.

Trends Biotechnol. 1996 Oct;14(10):364-9. Review.

PMID:
8987634
6.

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.

Houghton M.

Immunol Rev. 2011 Jan;239(1):99-108. doi: 10.1111/j.1600-065X.2010.00977.x. Review.

PMID:
21198667
7.

[The development of therapeutic vaccine for hepatitis C virus].

Kimura K, Kohara M.

Gan To Kagaku Ryoho. 2012 Oct;39(10):1451-7. Review. Japanese.

PMID:
23064054
8.

[The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].

Panther E, Spangenberg HC, Neumann-Haefelin C, Rösler K, Blum HE, von Weizsäcker F, Thimme R.

Z Gastroenterol. 2004 Jan;42(1):39-46. Review. German.

PMID:
14997402
9.

Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.

Larrubia JR, Benito-Martínez S, Miquel J, Calvino M, Sanz-de-Villalobos E, Parra-Cid T.

World J Gastroenterol. 2009 Nov 7;15(41):5129-40. Review.

10.

Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.

Alvarez-Lajonchere L, Dueñas-Carrera S.

Int Rev Immunol. 2012 Jun;31(3):223-42. doi: 10.3109/08830185.2012.680552. Review.

PMID:
22587022
11.

Immunological determinants of the outcomes from primary hepatitis C infection.

Post J, Ratnarajah S, Lloyd AR.

Cell Mol Life Sci. 2009 Mar;66(5):733-56. doi: 10.1007/s00018-008-8270-4. Review.

PMID:
19011759
12.

The role of immune responses in the pathogenesis of hepatitis C virus infection.

Koziel MJ.

J Viral Hepat. 1997;4 Suppl 2:31-41. Review.

PMID:
9429208
13.

Perspectives for a hepatitis C virus vaccine.

Abrignani S, Rosa D.

Clin Diagn Virol. 1998 Jul 15;10(2-3):181-5. Review.

PMID:
9741644
14.

Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.

Torresi J, Johnson D, Wedemeyer H.

J Hepatol. 2011 Jun;54(6):1273-85. doi: 10.1016/j.jhep.2010.09.040. Epub 2011 Jan 12. Review.

15.

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.

Feinstone SM, Hu DJ, Major ME.

Clin Infect Dis. 2012 Jul;55 Suppl 1:S25-32. doi: 10.1093/cid/cis362. Review.

PMID:
22715210
16.

Development of hepatitis C virus vaccines: challenges and progress.

Stoll-Keller F, Barth H, Fafi-Kremer S, Zeisel MB, Baumert TF.

Expert Rev Vaccines. 2009 Mar;8(3):333-45. doi: 10.1586/14760584.8.3.333. Review.

17.

The chimpanzee model of hepatitis C virus infections.

Lanford RE, Bigger C, Bassett S, Klimpel G.

ILAR J. 2001;42(2):117-26. Review.

PMID:
11406714
18.

Prospects for prophylactic hepatitis C vaccines based on virus-like particles.

Beaumont E, Roingeard P.

Hum Vaccin Immunother. 2013 May;9(5):1112-8. doi: 10.4161/hv.23900. Epub 2013 Feb 13. Review.

19.

Current progress in development of hepatitis C virus vaccines.

Liang TJ.

Nat Med. 2013 Jul;19(7):869-78. doi: 10.1038/nm.3183. Review.

PMID:
23836237
20.

Strategies and prospects for vaccination against the hepatitis C viruses.

Houghton M.

Curr Top Microbiol Immunol. 2000;242:327-39. Review. No abstract available.

PMID:
10592667

Supplemental Content

Support Center